April 1, 2013 / 11:04 AM / 7 years ago

India hails "historic" Supreme Court drug patent ruling against Novartis

NEW DELHI (Reuters) - The Indian government hailed as “historic” a Supreme Court ruling on Monday against a plea by Swiss drugmaker Novartis AG to protect the patent on its drug Glivec.

Commerce and Industry Minister Anand Sharma said the ruling — seen as a victory by health rights campaigners — reaffirmed provisions in Indian law that mandate the need for substantial innovation before new patents are issued on medicines.

Reporting By Matthias Williams; Writing by Frank Jack Daniel, editing by Ross Colvin

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below